Skip Navigation


NDT Advance Access originally published online on May 30, 2006
Nephrology Dialysis Transplantation 2006 21(9):2464-2471; doi:10.1093/ndt/gfl291
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/9/2464    most recent
gfl291v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tomiyama, C.
Right arrow Articles by Canziani, M. E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomiyama, C.
Right arrow Articles by Canziani, M. E. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Articles: Clinical Nephrology

The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients

Cristianne Tomiyama1, Andrea Higa1, Maria A. Dalboni1, Miguel Cendoroglo1, Sergio A. Draibe1, Lilian Cuppari1, Aluizio B. Carvalho1, Emilio M. Neto2 and Maria Eugenia F. Canziani1

1 Department of Internal Medicine/Nephrology Division, Federal University of São Paulo and 2 Brazil Diagnostic Center, São Paulo, Brazil

Correspondence and offprint requests to: Maria Eugênia F. Canziani, R. Pedro de Toledo 282, São Paulo, SP, Brazil, CEP 04039-000. Email: dialisefor{at}uol.com.br

Background. Coronary heart disease (CHD) is the leading cause of death among end-stage renal disease patients. There is evidence that coronary calcification is a marker of atherosclerotic vascular disease and is predictive of cardiovascular events, especially in patients on renal replacement therapy. It has recently been suggested that CHD begins in the pre-dialysis period. However, data regarding coronary calcification in this population is scarce. This study was aimed at evaluating such coronary calcification and identifying related factors.

Methods. A total of 96 chronic kidney disease out-patients who were not on dialysis were included. Patients presenting neoplastic, infectious or inflammatory diseases were excluded. Demographic characteristics, clinical profiles, laboratory test results and multislice computed tomography scans were evaluated.

Results. The median age was 55 years (range 20–69 years), 67% were men and the median creatinine clearance was 37 ml/min/1.73 m2. Coronary calcification, defined as a coronary artery calcification score (CACS) >0 Agatston units (AU), was seen in 61 patients (median 89.1 AU, range 0.37–2299.3 AU). On average, these patients were older, more often had diabetes, higher body mass indices and higher Framingham risk indices, as well as presenting higher proteinuria, intact parathyroid hormone (iPTH), blood glucose and triglyceride levels compared with those without calcification. Multiple logistic regression analysis, adjusted for age and diabetes, identified iPTH and triglyceride levels as independent determinants of calcification. Severe calcification (CACS >400 AU) was seen in 22 patients, who were also older and more frequently had a history of cardiovascular disease (CVD), as well as having higher levels of phosphorus, blood glucose and soluble Fas (sFas). Multiple logistic regression analysis, adjusted for age and diabetes, identified phosphorus and sFas levels as independent determinants of severe coronary calcification.

Conclusion. Coronary calcification is highly prevalent in pre-dialysis patients and correlates with traditional and non-traditional risk factors for CVD.

Keywords: chronic kidney disease; coronary arteriosclerosis; multislice computed tomography; vascular calcification


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Morena, A.-M. Dupuy, I. Jaussent, H. Vernhet, G. Gahide, K. Klouche, A.-S. Bargnoux, C. Delcourt, B. Canaud, and J.-P. Cristol
A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3389 - 3397.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. F. Navarro-Gonzalez, C. Mora-Fernandez, M. Muros, H. Herrera, and J. Garcia
Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study
Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1646 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. D. Parker, J. H. Ix, E. C. M. Cranenburg, C. Vermeer, M. A. Whooley, and L. J. Schurgers
Association of kidney function and uncarboxylated matrix Gla protein: Data from the Heart and Soul Study
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2095 - 2101.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. N. Foley
Phosphate Levels and Cardiovascular Disease in the General Population
Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1136 - 1139.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. G. Graciolli, K. R. Neves, L. M. dos Reis, R. G. Graciolli, I. L. Noronha, R. M. A. Moyses, and V. Jorgetti
Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia
Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1416 - 1421.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
S. Brincat and D. J. Goldsmith
Review: Vascular calcification in chronic kidney disease: the tip of the chalk-berg
The British Journal of Diabetes & Vascular Disease, November 1, 2008; 8(6): 264 - 271.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
K. A. Barraclough, L. A. Stevens, L. Er, D. Rosenbaum, J. Brown, P. Tiwari, and A. Levin
Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3199 - 3205.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. H. Ix, R. Katz, B. Kestenbaum, L. F. Fried, H. Kramer, C. Stehman-Breen, and M. G. Shlipak
Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 579 - 585.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Caglar, M. I. Yilmaz, M. Saglam, E. Cakir, C. Acikel, T. Eyileten, M. Yenicesu, Y. Oguz, A. Vural, J. J. Carrero, et al.
Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. P. Kovesdy, R. Mehrotra, and K. Kalantar-Zadeh
Battleground: Chronic Kidney Disorders Mineral and Bone Disease Calcium Obsession, Vitamin D, and Binder Confusion
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 168 - 173.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. J. Porter, A. Stavroulopoulos, S. D. Roe, K. Pointon, and M. J.D. Cassidy
Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3208 - 3213.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.